Frazier Life Sciences Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.5M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $304K | Hold |
|
|||||
|
2024
Q2 | $291K | Hold |
|
|||||
|
2024
Q1 | $328K | Hold |
|
|||||
|
2023
Q4 | $278K | Hold |
|
|||||
|
2023
Q3 | $1.81M | Hold |
|
|||||
|
2023
Q2 | $2.74M | Hold |
|
|||||
|
2023
Q1 | $2.14M | Sell |
|
|||||
|
2022
Q4 | $4.57M | Sell |
|
|||||
|
2022
Q3 | $6.43M | Hold |
|
|||||
|
2022
Q2 | $5.7M | Hold |
|
|||||
|
2022
Q1 | $7.04M | Buy |
|